ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

DRRX Durect Corp

0.7957
0.00 (0.00%)
Last Updated: 12:45:14
Delayed by 15 minutes

Period:

Draw Mode:

Volume 17,660
Bid Price 0.765
Ask Price 0.7957
News -
Day High 0.7957

Low
0.4703

52 Week Range

High
7.46

Day Low 0.75
Company Name Stock Ticker Symbol Market Type
Durect Corp DRRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.00% 0.7957 12:45:14
Open Price Low Price High Price Close Price Prev Close
0.7949 0.75 0.7957 0.7957
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
94 17,660 $ 0.7621724 $ 13,460 - 0.4703 - 7.46
Last Trade Time Type Quantity Stock Price Currency
12:52:00 1 $ 0.7957 USD

Durect Corp Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
22.97M 29.83M - 8.55M -27.62M -0.93 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Durect News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No DRRX Message Board. Create One! See More Posts on DRRX Message Board See More Message Board Posts

Historical DRRX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.920.920.72350.8078982120,627-0.1243-13.51%
1 Month1.321.350.72351.07138,575-0.5243-39.72%
3 Months0.771.410.68020.9882688176,9440.02573.34%
6 Months2.533.140.47030.9377917488,400-1.73-68.55%
1 Year4.547.460.47031.74346,747-3.74-82.47%
3 Years17.8019.300.47037.15481,842-17.00-95.53%
5 Years6.3041.000.470315.52783,714-5.50-87.37%

Durect Description

Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from the United States.

Your Recent History

Delayed Upgrade Clock